Last month, the 23-acute-hospital company reported its fourth-quarter profits were $135.5 million, up 42 percent year-over-year, with much of the success attributable to federal incentives for electronic health record. Its fiscal year 2012 profit was up 11.4 percent to $443.4 million. In March, UHS’ stock cleared the $60 per share mark, the highest of any for-profit hospital stock.
Mr. Filton, a CPA, earned a bachelor’s degree in accounting from the Wharton School of the University of Pennsylvania.
If you have more information or updates for this profile or would like to recommend a leader to be profiled in the future, please contact Lindsey Dunn, editor in chief, Becker’s Hospital Review at ldunn@beckershealthcare.com.
More Articles on Hospital CFO Profiles:
CFO Gary McLaughlin: Upgraded Outlook at Overlake Hospital Medical Center
CFO David Nelson: Breadth of Experience at Hospital Sisters Health System
CFO Karen Lumpp: Fiscal Dexterity at Trinitas Regional Medical Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
